Company: EUDAW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001493152-25-011729
Chunk: 21

Company: EUDA Health Holdings Ltd
Filing Date: 2025-08-08
Form: 424B5
Chunk 21
---
 the Transfer Agent to transmit the shares to the Investor, and if the Investor is required to purchase or the brokerage firm purchases, the shares in satisfaction of a sale of the conversion shares, the Company will: (A) pay the Investor in cash the difference between the Investor’s total purchase price for the shares and the amount obtained by multiplying the number of conversion shares by the price at which the related sell order was executed, and (B) at the Investor’s option, either reinstate the portion of the Convertible Note and equivalent number of shares for which such exercise was not honored (deeming the exercise rescinded) or deliver the number of shares the Investor should have received. No fractional shares will be issued upon conversion.

Share Dividends and Splits

If the Company, while this Convertible Note is outstanding and not fully converted, (i) pays a share dividend or makes a distribution on its Ordinary Shares, (ii) subdivides its shares, (iii) combines its shares (including reverse split), or (iv) reclassifies its capital stock, the conversion price will be adjusted. The new conversion price will be multiplied by a fraction where the numerator is the number of Ordinary Shares outstanding before the event and the denominator is the number of shares outstanding after. The total conversion price of this Note remains unchanged.

Subsequent Rights Offerings

If the Company grants, issues, or sells Ordinary Shares or equivalent rights to purchase shares, securities, or other property to its shareholders pro rata (“Purchase Rights”), the holder will have the right to acquire the same Purchase Rights as if the holder had fully converted the Convertible Note into Ordinary Shares before the record date of the offering. However, if exercising such rights would cause the Investor to exceed the 4.99% limitation, the rights will be held in abeyance until the Investor can exercise them without exceeding the limitation.

Pro Rata Distributions

If the Company, while this Convertible Note is outstanding and not fully converted, declares or makes any dividend or distribution of its assets (or rights to acquire its assets) to the holders of Ordinary Shares, the Investor will be entitled to participate in the distribution as if the Investor had fully converted the Convertible Notes into Ordinary Shares before the record date. However, if participating would cause the Investor to exceed the 4.99% limitation, the excess portion will be held in abeyance until the Investor can participate without exceeding the limitation.

Fundamental Transaction

If the Company, while this Convertible Note is outstanding and not fully converted